Watchful waiting

How a single data event completely remade cancer play Celator's investor base

New SEC ownership filings reveal how a single data event completely revamped the shareholder base of Celator Pharmaceuticals Inc. (NASDAQ:CPXX). Overnight, the company's sub-$100 million valuation jumped to $308.8 million and the retail crowd that dominated its investor

Read the full 381 word article

How to gain access

Continue reading with a
two-week free trial.